CAPTRUST FINANCIAL ADVISORS

Position in FATE — Fate Therapeutics Inc

CIK 1512024 RALEIGH, NC

Position in FATE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$50,256

+$25,233 QoQ

Shares Held

41,880

+64.0% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 41.48280802292263.ToString("F0")% Shared 0.ToString("F0")% None 58.51719197707737.ToString("F0")%

Healthcare · as of Mar 31, 2026

CAPTRUST FINANCIAL ADVISORS holds $130,226,430 across 94 Biotechnology names. FATE ranks #77 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	38,502	$29,748,185
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,092	$14,330,361
3	EXEL	Exelixis, Inc.	312,296	$13,394,375
4	HALO	Halozyme Therapeutics, Inc.	121,088	$7,825,917
5	CELC	Celcuity Inc.	61,068	$6,970,301
6	RPRX	Royalty Pharma plc	143,760	$6,896,167
7	LGND	Ligand Pharmaceuticals Inc	29,900	$5,969,535
8	INCY	Incyte Corp	53,555	$5,040,596

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$50,256	41,880	+64.0%	Shares	Sole	2026-05-15
2025-12-31	$25,023	25,534	+31.0%	Shares	Sole	2026-02-17
2025-09-30	$24,556	19,489	-0.6%	Shares	Sole	2025-11-19
2025-06-30	$21,956	19,604	+19.3%	Shares	Sole	2025-08-15
2025-03-31	$12,978	16,429	+3366.0%	Shares	Sole	2025-05-15
2022-06-30	$11,745	474	+5166.7%	Shares	Sole	2022-08-23
2022-03-31	$348	9	-82.0%	Shares	Sole	2022-05-16
2021-12-31	$2,925	50	+100.0%	Shares	Sole	2022-02-14
2021-09-30	$1,481	25	-60.3%	Shares	Sole	2021-11-16
2021-06-30	$5,467	63	-16.0%	Shares	Sole	2021-08-16
2021-03-31	$6,183	75	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.